Skip to search formSkip to main contentSkip to account menu

SKLB-M8

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals
ABSTRACT Tuberculosis is a major global health problem, and the emergence of multidrug-resistant and extensively drug-resistant… 
2017
2017
A novel benzothiazinethione analogue SKLB-TB1001 displays potent antimycobacterial activities in a series of murine models.
2014
2014
SKLB-M8 induces apoptosis through the AKT/mTOR signaling pathway in melanoma models and inhibits angiogenesis with decrease of ERK1/2 phosphorylation.
SKLB-M8, a derivative of millepachine, showed significant anti-proliferative effects in melanoma cell lines. In this study, we… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)